Simple balloon occlusion to seal sub artery peroration - Case by Dr MV Reddy Meghna Singhania28 Feb 2018 3:22 PM ISTInternal jugular vein catheterization is a common practice in the intensive care unit and in operative room , for transfusion of medication, fluids,...
Aspirin+ticagrelor improves outcomes after elective CABG Medha Baranwal Baranwal26 April 2018 8:30 PM ISTAdministration of dual antiplatelet therapy (DAPT) comprising of aspirin plus ticagrelor, for one year after coronary artery bypass grafting (CABG)...
Long-term antiplatelet monotherapy not superior to DAPT: GLOBAL LEADERS Trial Medha Baranwal Baranwal1 Sept 2018 7:20 PM ISTLong-term antiplatelet monotherapy -- ticagrelor in combination with aspirin for 1 month followed by ticagrelor alone for 23 months -- is safe after...
Stopping aspirin 3 months after stenting does not increase death risk: ACC Medha Baranwal Baranwal21 March 2019 8:10 PM ISTDELHI: Aspirin has long been known to reduce the risk of stroke, heart attack, and cardiovascular disease. However, a new study presented at the...
What is the optimum medical therapy for diabetes management: Status 2019 Medha Baranwal Baranwal18 April 2019 7:03 PM ISTDiabetes in 2019 has been understood as a multi-organ and a multi-specialty disease. It affects the eyes, nerves, kidney, vessels, brain, and heart...
Peripheral artery disease increases risk of Stroke and TIA: EUCLID clinical trial Medha Baranwal Baranwal23 Jun 2019 7:15 PM ISTDelhi: Patients with symptomatic peripheral artery disease (PAD) are at increased risk of stroke and transient ischemic attack (TIA), according to...
Ticagrelor plus Aspirin have moderate benefits but greater bleeding risk in High Blood Sugar and CAD: ESC 2019 update Deepanjana Sarkar3 Sept 2019 8:28 PM ISTBoston, MA -- Ticagrelor plus aspirin is associated with a lower incidence of ischemic cardiovascular events such as heart attacks, strokes in...
Ticagrelor or Prasugrel?? Which antiplatelet therapy is best to treat ACS Deepanjana Sarkar5 Sept 2019 7:28 PM ISTPrasugrel and ticagrelor, novel antiplatelet agents have emerged as advanced oral antiplatelet therapy for patients with Acute Coronary Syndromes...
DAPT with aspirin prevents saphenous vein graft failure in CABG, finds BMJ study Dr. Kamal Kant Kohli Kohli13 Oct 2019 8:30 PM ISTCanada: Aspirin is the preferred antiplatelet drug for the prevention of saphenous vein graft failure in patients undergoing coronary artery bypass...
Ticagrelor monotherapy after 1 month of DAPT good enough after multivessel PCI: JACC Dr. Kamal Kant Kohli Kohli6 Nov 2019 8:20 PM ISTThere is no absolute clarity on the duration of antiplatelet therapy after angioplasty in patients with multiple vessel disease. Moreover, the data on...
Stopping Aspirin after 3 months of DAPT okay in high risk patients: TWILIGHT Medha Baranwal Baranwal25 Nov 2019 8:20 PM ISTSubgroup analysis of ticagrelor alone versus ticagrelor + aspirin in NSTE-ACS after PCI found less clinically relevant bleeding; similar rates of...
Ticagrelor not entirely safe, linked to major bleeding in ACS patients after PCI: JAMA Dr. Prem Aggarwal14 Jan 2020 9:00 PM ISTCanada: The use of ticagrelor -- which is recommended over clopidogrel in AHA/ACC guidelines— increases major bleeding and dyspnea in acute coronary...
